Psychiatry and Neurology, Neurology · San Francisco, CA
NPI
1861460990
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1100 Van Ness Ave
San Francisco, CA, 94109
Phone (415) 600-7880
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
362 services
Medicare patients, 2024
215
Average age 70
Drug cost, 2024
$981K
1,311 prescriptions
Company payments, 2025
$59K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth D Laxer was code 95720 (neurologic), 101 times for 53 patients. In total Kenneth D Laxer billed 362 services in 15 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 101 | 53 | $179.41 | $18K |
| 99214 Office E&M - Established | Office | 99 | 59 | $99.58 | $9,858 |
| 95717 Neurologic | Facility | 35 | 33 | $89.16 | $3,121 |
| 95816 Neurologic | Facility | 28 | 28 | $46.14 | $1,292 |
| 95718 Neurologic | Facility | 21 | 20 | $117.11 | $2,459 |
| 95813 Neurologic | Facility | 20 | 18 | $75.44 | $1,509 |
| 99213 Office E&M - Established | Office | 14 | 13 | $66.47 | $931 |
| 99215 Office E&M - Established | Office | 13 | 12 | $150.67 | $1,959 |
| 95819 Neurologic | Facility | 12 | 12 | $41.37 | $496 |
By year: 2022 $35K for 315 services; 2023 $40K for 329 services; 2024 $42K for 362 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth D Laxer prescribed most often to Medicare patients was Xcopri (Cenobamate), with 207 prescriptions and refills. In total Kenneth D Laxer wrote 1,311 Medicare prescriptions that cost $981K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xcopri Cenobamate | 207 | 213 | 18 | $294K |
| Clobazam Generic | 154 | 181 | 18 | $18K |
| Levetiracetam Generic | 139 | 251 | 24 | $8,177 |
| Fycompa Perampanel | 122 | 138 | 12 | $169K |
| Lamotrigine Generic | 106 | 227 | 22 | $2,072 |
| Lacosamide Generic | 103 | 169 | 19 | $18K |
| Lamotrigine Er Lamotrigine | 97 | 169 | 15 | $50K |
| Lorazepam Generic | 41 | 41 | 14 | $160 |
| Briviact Brivaracetam | 39 | 45 | Under 11 | $85K |
| Lamictal Xr Lamotrigine | 39 | 53 | Under 11 | $61K |
| Vimpat Lacosamide | 24 | 24 | Under 11 | $57K |
| Keppra Levetiracetam | 22 | 38 | Under 11 | $53K |
| Levetiracetam Er Levetiracetam | 21 | 39 | Under 11 | $2,555 |
| Divalproex Sodium Er Divalproex Sodium | 21 | 53 | Under 11 | $1,314 |
| Carbamazepine Er Carbamazepine | 17 | 41 | Under 11 | $4,976 |
Brand drugs: - claims; generic drugs: 793 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth D Laxer $59K ($59K in general payments such as food, travel and fees) from 4 companies. The largest payer was SK Life Science, Inc. with $59K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.